Adds to existing law to establish provisions regarding directed blood product transfusion.
Summary
House Bill 400 creates a new section of Idaho law governing directed blood product transfusions. It defines “blood product” broadly to include whole blood, plasma, derivatives, platelets, and clotting agents, and generally prohibits health care providers and facilities from barring a patient from supplying their own blood or blood from a directed donor through a blood establishment that complies with federal collection requirements.
The bill allows exceptions when the donation or transfusion would be harmful to the donor or patient, when there is not enough time to arrange the blood before a surgery or procedure, or when the procedure is an emergency. It also provides liability protection for providers and facilities using patient-supplied blood, unless gross negligence related to the blood product or transfusion contributed to injury, damage, or death. The bill states that it does not conflict with federal law and takes effect July 1, 2025, under an emergency clause.
Impact
The bill would add a new statutory provision to Title 39, Chapter 37 of the Idaho Code, limiting the ability of hospitals and other health care facilities to refuse directed or patient-provided blood for transfusions. It affects health care providers, hospitals, surgical facilities, blood establishments, patients who want directed donations, and donors, while preserving compliance with federal blood-collection rules and carving out emergency and medical-safety exceptions. It also creates a gross-negligence standard for liability when patient-supplied blood is used.
Sentiment
Based on the bill text and available context, the measure appears to be presented as a health care access and patient-choice bill, with no recorded committee transcript or vote history showing opposition or support. The emergency clause and effective date suggest the sponsors viewed the issue as time-sensitive. Overall, the available record does not show significant public debate in the provided materials, but the structure of the bill indicates an intent to accommodate directed donation preferences while maintaining provider protections.
Contention
The main points of potential contention are patient autonomy versus provider discretion and safety. Supporters would likely favor the bill for allowing patients to use their own or directed-donor blood, while health care providers may be concerned about logistical burdens, timing constraints, and liability exposure. The bill addresses some of those concerns by allowing exceptions for medical necessity, emergencies, and insufficient time, and by granting immunity absent gross negligence. Federal compliance is another possible issue, but the bill expressly disclaims any conflict with federal law.